Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

Patient Engagement Book Image

Moving away from pharma’s paternalistic approach

New handbook makes the case for greater patient engagement in the development of new medicines

Cuttsy + Cuttsy

The PT Marketer of the Year competition due to close this Friday

Enter directly or nominate a colleague or team member

- PMLiVE

Health secretary’s ‘rip off’ remarks anger UK pharma

Row with Vertex has tainted government-industry relations

- PMLiVE

Takeda rebels take aim at Shire acquisition

Shareholder group concerned about $30bn debt burden

Roche Basel Switzerland

Dismay as NICE rejects Roche’s MS drug Ocrevus

Treatment deemed too costly to treat primary progressive MS

- PMLiVE

Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership team

The latest industry movers

- PMLiVE

WPP stays in familiar hands with new chief exec

Read also unveils restructuring plans

- PMLiVE

MSD wins key EU approval for Keytruda, Alimta combo

Decision keeps Keytruda well ahead of rival Tecentriq

- PMLiVE

Stepping up for Leeds Mind

On 31st August 2018 the team at Mednet Group walked 27.5km across Yorkshire and raised £1,713.00 for local charity, Leeds Mind. A charity which promotes positive mental health and wellbeing...

Mednet

- PMLiVE

FDA rejects GSK’s Nucala for COPD

Says evidence that Nucala was effective in preventing COPD exacerbations was insufficient

- PMLiVE

NICE turns down Opdivo for adjuvant melanoma therapy

BMS drug currently only licensed treatment in this setting

AstraZeneca AZ

AZ, Amgen’s first-in-class asthma drug gets breakthrough status

Clinical data from the TSLP targeting antibody is due in 2020

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links